BCG Immunotherapy in Bladder Cancer: A Reassessment
- 8 April 1988
- journal article
- Published by American Medical Association (AMA)
- Vol. 259 (14) , 2153
- https://doi.org/10.1001/jama.1988.03720140069039
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- BCG in management of superficial bladder cancerUrology, 1987
- Bacillus Calmette-Guerin for Treatment of Superficial Transitional Cell Carcinoma of the Bladder in Patients who have failed Thiotepa and/or Mitomycin CJournal of Urology, 1987
- Interleukin-2 production during intravesical bacille Calmette-Guerin therapy for bladder cancerClinical Immunology and Immunopathology, 1986
- Bacillus Calmette-Guerin for Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, 1986
- Bacillus Calmette-Guerin Immunotherapy of Infiltrating Bladder CancerJournal of Urology, 1984
- Long-Term Results and Complications of Intracavitary Bacillus Calmette-Guerin Therapy for Bladder CancerJournal of Urology, 1984
- Long Term Protection in Bladder Cancer Following Intralesional ImmunotherapyJournal of Urology, 1984
- BCG in the management of superficial bladder cancerUrology, 1984
- A Comparison of Treatment Methods for the Prophylaxis of Recurrent Superficial Bladder TumorsJournal of Urology, 1983
- Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1982